| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/07/2011 | US20110166110 Fused Ring Azadecalin Glucocorticoid Receptor Modulators |
| 07/07/2011 | US20110166104 Boron-containing small molecules |
| 07/07/2011 | US20110166097 Taxane compounds for treating eye disease |
| 07/07/2011 | US20110166060 Tympanic membrane permeating ear drops and uses thereof |
| 07/07/2011 | US20110165235 Directly pressed aliskiren tablets |
| 07/07/2011 | US20110165232 Use of Opioid Antagonists for the Preparation of a Medicament in the Treatment of Retinal Degenerative Diseases |
| 07/07/2011 | US20110165229 Compositions and Methods for Treatment |
| 07/07/2011 | US20110165228 Compositions and Methods for Treatment |
| 07/07/2011 | US20110165167 Noval madcam antibodies |
| 07/07/2011 | US20110165142 Method of treating degenerative diseases |
| 07/07/2011 | US20110165114 Drug delivery composition |
| 07/07/2011 | US20110165096 Ficus Extracts Having Angiogenesis Ihibiting Activity And Methods Of Isolating And using The Same |
| 07/06/2011 | EP2341048A1 Thiazolium salt compound and the use of treating the protein aging disease |
| 07/06/2011 | EP2341045A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid (acyloxy)alkyl or ((alkoxycarbonyl)oxy)alkyl ester as SPLA2 inhibitor |
| 07/06/2011 | EP2340242A2 Compounds for treating ophthalmic diseases and disorders |
| 07/06/2011 | EP2340014A1 Eye drop with difluprednate for macular edema treatment |
| 07/06/2011 | EP1802373B1 Carboxy-amido-triazoles for the localized teatment of ocular diseases |
| 07/06/2011 | EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
| 07/06/2011 | EP1317283B1 Tweak receptor agonists as anti-angiogenic agents |
| 07/06/2011 | EP1228076B1 A substantially cell membrane impermeable compound and use thereof |
| 07/06/2011 | CN1965825B Ocular surface applied medicament for treating eyes immunological disease and inhibiting proliferation and neovascularization |
| 07/06/2011 | CN102114245A Special solvent for daidzein pre-emulsified injection and preparation method and purpose thereof |
| 07/06/2011 | CN102114193A Traditional Chinese medicine for treating keratomalacia due to vitamin A deficiency |
| 07/06/2011 | CN102114181A Medicament for treating dry eye |
| 07/06/2011 | CN102114145A Traditional Chinese medicine oral decoction for treating otitis media suppurativa |
| 07/06/2011 | CN102114126A Traditional Chinese medicine for treating diabetic retinopathy |
| 07/06/2011 | CN102114125A Traditional Chinese medicine composition for treating trachoma |
| 07/06/2011 | CN102114120A Traditional Chinese medicine for treating diabetic eye diseases |
| 07/06/2011 | CN102114106A Traditional Chinese medicine oral decoction for treating tympanitis |
| 07/06/2011 | CN102114044A Artificially processed bear bile powder and preparation method thereof |
| 07/06/2011 | CN102114020A Pharmaceutical composition containing besivance or salts thereof and preparation method thereof |
| 07/06/2011 | CN101052397B 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 07/05/2011 | US7973170 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/05/2011 | US7973160 Nitrogen-containing aromatic derivatives |
| 07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
| 07/05/2011 | US7972629 Product comprising a combination of milk serum apoproteins and free fatty acids |
| 07/05/2011 | US7972612 Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker |
| 07/05/2011 | CA2511568C Radiopaque animal chew |
| 07/05/2011 | CA2486728C Novel physiologically active substances useful for suppressing vegf production |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/05/2011 | CA2457319C Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs |
| 07/05/2011 | CA2450466C 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 07/05/2011 | CA2401491C Ccr4-binding antibody and diagnostic and therapeutic uses thereof |
| 06/30/2011 | WO2011079232A1 Sustained release delivery devices |
| 06/30/2011 | WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | WO2011078303A1 Aminopyridine compound |
| 06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
| 06/30/2011 | WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same |
| 06/30/2011 | WO2011078102A1 Novel phenoxypyrimidine derivative |
| 06/30/2011 | WO2011077800A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages |
| 06/30/2011 | WO2011077711A1 Novel 2-pyridone derivative and pharmaceutical product containing same |
| 06/30/2011 | WO2011077587A1 Composition for inhibiting allergic diseases |
| 06/30/2011 | WO2011077435A1 Compositions and methods for reducing intraocular pressure |
| 06/30/2011 | WO2011076869A1 Isolated green plant material |
| 06/30/2011 | WO2011076811A1 Carboxamide compounds and their use as calpain inhibitors |
| 06/30/2011 | WO2011075838A1 Method of treating or preventing hearing loss |
| 06/30/2011 | WO2011045383A3 2, 6 -diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases |
| 06/30/2011 | US20110160309 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
| 06/30/2011 | US20110160308 Use of Monoamine Oxidase Inhibitors to Treat Outer Retina Disorders |
| 06/30/2011 | US20110160279 METHODS FOR TREATMENT AND PREVENTION OF OTOTOXICITY BY siRNA |
| 06/30/2011 | US20110160277 Modulation of 11 beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases |
| 06/30/2011 | US20110160271 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 06/30/2011 | US20110160262 Method of treating retinal vein occlusion |
| 06/30/2011 | US20110160240 Polymorphs and salts of a kinase inhibitor |
| 06/30/2011 | US20110160214 Compositions and methods for eye whitening |
| 06/30/2011 | US20110160210 Control of intraocular pressure using alk5 modulation agents |
| 06/30/2011 | US20110160181 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 06/30/2011 | US20110160172 Fluoroquinolone derivatives for ophthalmic applications |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110159131 Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels |
| 06/30/2011 | US20110159098 Stabilization and delivery of nucleic acid complexes |
| 06/30/2011 | US20110159016 Hemoglobin-based methods for prophylaxis, diagnosis and/or treatment of retinal disorders |
| 06/30/2011 | US20110159004 Methods and Compositions for Preserving the Viability of Photoreceptor Cells |
| 06/30/2011 | US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof |
| 06/30/2011 | US20110158968 Methods of making enhanced, autologous fat grafts |
| 06/30/2011 | US20110158961 Materials and methods relating to cell based therapies |
| 06/30/2011 | US20110158958 Methods for treating ophthalmic disorders, diseases and injuries |
| 06/30/2011 | US20110158956 Treating cancer |
| 06/30/2011 | CA2785668A1 Aminopyridine compound |
| 06/30/2011 | CA2785468A1 Sustained release delivery devices |
| 06/30/2011 | CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | CA2783704A1 Carboxamide compounds and their use as calpain inhibitors |
| 06/30/2011 | CA2782796A1 Compositions and methods for the treatment of angiogenesis-related eye diseases |
| 06/29/2011 | EP2338915A2 Anti-VEGF antibodies |
| 06/29/2011 | EP2338914A1 Connective tissue growth factor antibodies |
| 06/29/2011 | EP2338899A1 Peptides for activation and inhibition of delta PKC |
| 06/29/2011 | CN1942183B Isosorbide-containing jelly preparation |
| 06/29/2011 | CN102112112A Controlled release antimicrobial compositions and methods for treatment of otic disorders |
| 06/29/2011 | CN102112111A Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| 06/29/2011 | CN102108346A Method for preparing lysozyme |
| 06/29/2011 | CN102106977A Externally-applied sturdy vision eyeshield liquid medicine for preventing and treating oculopathy |
| 06/29/2011 | CN102106967A Eyesight-improving capsule for treating fundus hemorrhage |
| 06/29/2011 | CN102106951A Chinese medicinal preparation for treating glaucoma |
| 06/29/2011 | CN102106907A Quality control method for rhubarb (traditional Chinese medicine) ethanol-extraction process |
| 06/29/2011 | CN102106884A Medicinal composition having immunity-regulating function |
| 06/29/2011 | CN102106812A Azithromycin ultrafine powder in-situ gel eye drops and preparation method thereof |
| 06/29/2011 | CN102106796A Nutritional health-care product for adjusting visual performance |